PAC5 Overview

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 2

PAC5 General Information

Description

Developer of preventative screening tools designed to catch and find hereditary cancers at an early stage. The company utilizes technology with deoxyribonucleic acid(DNA) sequencing in genetics testing along with enhanced imaging to develop an evidence-based program, enabling patients to bypass chemotherapy and get improved cancer treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Corporate Office
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Decision/Risk Analysis
Vertical(s)
Corporate Office
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PAC5 Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PAC5‘s full profile, request access.

Request a free trial

PAC5 FAQs

  • Where is PAC5 headquartered?

    PAC5 is headquartered in .

  • What industry is PAC5 in?

    PAC5’s primary industry is Diagnostic Equipment.

  • Is PAC5 a private or public company?

    PAC5 is a Private company.

  • What is PAC5’s current revenue?

    The current revenue for PAC5 is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process